Clinical Research Directory
Browse clinical research sites, groups, and studies.
Travoprost Intraocular Implant + iStent Infinite vs. iStent Infinite Alone
Sponsor: Glaukos Corporation
Summary
Adult subjects with elevated intraocular pressure who have successfully undergone placement of iStent infinite trabecular bypass system will be randomized to receive a travoprost intraocular implant or receive a sham procedure and be followed for 12 months.
Official title: Multicenter, Randomized, Double-masked Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intraocular Implant) in Conjunction With the Placement of iStent Infinite vs. iStent Infinite Alone in Subjects With Open-angle Glaucoma or Ocular Hypertension
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
230
Start Date
2023-09-14
Completion Date
2028-02
Last Updated
2026-01-21
Healthy Volunteers
No
Conditions
Interventions
Travoprost Intraocular Implant
anchored intracameral implant containing travoprost in subjects who successfully received iStent infinite
Sham procedure 1
Sham procedure (to mimic placement of travoprost intraocular implant) in subjects who successfully received iStent infinite
iStent infinite
Successful iStent infinite surgery
Sham procedure 2
Sham procedure (to mimic placement of an iStent infinite)
Locations (1)
Glaukos Clinical Study Site
Colorado Springs, Colorado, United States